Celestial Labs IPO
Celestial Labs IPO — date, price band, lot size & details 2007
Celestial Labs listed on 17 Jul 2007 at ₹75, 25% above the ₹60 issue price.
Celestial Labs is an Andhra Pradesh biotechnology and bioinformatics company that developed CELSUITE, a drug design tool for the pharma industry. It had 94 employees at the time of its IPO.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 12 November.
- Open 18 Jun 2007
- Close 22 Jun 2007
- Allotment TBA
- Refund/credit TBA
- Listing 17 Jul 2007
Issue summary
The terms of the offer, as filed.
| IPO Dates | 18 to 22 Jun, 2007 |
|---|---|
| Price Band | TBA |
| Face Value | ₹10 |
| Lot Size | 90 Shares |
| Issue Size | ₹30 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE, NSE |
| Registrar | KFin Technologies Limited |
| Min Investment | ₹ 5,400 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 90 shares at the ₹60 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 90 | ₹5,400 |
| Retail (max) | 37 | 3,330 | ₹1,99,800 |
| S-HNI (min) | 38 | 3,420 | ₹2,05,200 |
| S-HNI (max) | 185 | 16,650 | ₹9,99,000 |
| B-HNI (min) | 186 | 16,740 | ₹10,04,400 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01It had its own drug design tool, CELSUITE, for 1 key market, pharma drug discovery.
- 02Return on net worth was 24.7%.
- 03It had 94 employees with skills in biotech and bioinformatics.
- 04The whole Rs 30 crore issue was fresh money for the company.
Risks · 5
- 01It was a very small company with 94 employees.
- 02Biotech and bioinformatics rules can change and affect its business, with only 1 core product.
- 03Its expansion plans could cost more or take longer than its 1 estimate.
- 04Drug discovery tools depend on a few pharma clients and their research budgets; the issue was only Rs 30 crore.
- 05Promoter and relatives' holding fell from 64.06% before the issue to 35.44% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Celestial Labs offer document.
| Metric | 31 Mar 2007 | 31 Mar 2006 | 31 Mar 2005 | 31 Mar 2004 |
|---|---|---|---|---|
| Assets | 24.24 | 16.42 | 11.96 | 8.94 |
| Total Income | 14.13 | 10.22 | 8.07 | 5.03 |
| Profit After Tax | 5.14 | 3.28 | 2.65 | 0.93 |
| NET Worth | 20.83 | 14.57 | 10.50 | 7.28 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Celestial Labs RHP.
Where the money goes
₹40.59 Cr of the issue is earmarked to named objects.
About the company
It works in biotechnology and bioinformatics, and developed CELSUITE, a drug design tool to help the pharma industry in drug discovery.
It had a workforce of 94 employees, and planned to use the IPO money to broaden its production capacity and for working capital.
The IPO was Rs 30 crore and was entirely a fresh issue at a fixed price of Rs 60, 6 times the face value.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Celestial Labs IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Chartered Capital & Investment Ltd
13 issues handledBest listing: Kamdhenu Ispat (+24.0%). Weakest: AMD Metplast (-2.7%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Celestial Labs?
The current Grey Market Premium is ₹0.
What is the Celestial Labs IPO price band?
₹60, on a face value of ₹10.
When is the allotment?
The basis of allotment is TBA, with listing on 17 July 2007.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
